Abuse of prescription buprenorphine, regulatory controls and the role of the primary physician.

Abstract

INTRODUCTION Buprenorphine is an opioid partial agonist approved in several countries for the treatment of opioid dependence. It was approved in Singapore in 2002 for this indication, and is more widely available in the primary care setting and can be prescribed by all licensed physicians who have undergone designated training. There is limited literature… (More)

Topics

  • Presentations referencing similar topics